• Describe narcotic counts associated with different storage methods. • Describe 7 types of administration. • List at least 8 common side effects for both opiate agonists and opiate agonist-antagonists. • Describe the use of opiate antagonists. • Describe important elements to …

the Narcotic Treatment Program Manual (NTP Manual) to assist you in understanding the provisions of the Controlled Substances Act (CSA). This NTP Manual will answer questions

Drug Enforcement Administration Pharmacist’s Manual EO-DEA154R1, DEA-DC-046R1. 2022 Edition Page 2 . Anne Milgram Administrator . Drug Enforcement Administration

There are three sections to this checklist: Treatment, Patient Confidentiality, and Harm Reduction. There are three FDA-approved medications for opioid use disorder (MOUD): methadone, naltrexone, and buprenorphine.

Controlled drugs, as determined by the facility, are counted every shift by the nurse reporting on duty with the nurse reporting off-duty. The inventory of the controlled drugs must be recorded on the narcotic records and signed for accuracy of count.

Recommended practices in this Practitioner’s Manual are voluntary and use language such as “should” or “recommend” to identify these suggestions. Readers should refer to the most current versions of the CSA, DEA regulations, and Federal Register notices to obtain the most complete and accurate up-to-date statutory and regulatory information.

Controlled substances must be signed into the narcotic book immediately upon receipt from the pharmacy. TIP: Check the count before accepting from the delivery driver for all controlled substances, including the ER narcotic kit.

Controlled Substance Compliance – PIC Checklist Instructions: The Pharmacist-In-Charge (PIC) is to review and update section 1 checklist/information at least annually. Upon

CDC Checklist for Prescribing Opioids for Chronic Pain For primary care providers treating adults (18+) with chronic pain ≥ 3 months, excluding cancer, palliative, and end-of-life care; CDC Guideline for Prescribing Opioids for Chronic Pain Factsheet Determining when to initiate or continue opioids for chronic pain

The Oklahoma Bureau of Narcotics (OBN) is authorized by Title 63 of the Oklahoma Statutes to enforce the Uniform Controlled Dangerous Substance Act. They require registration by scientific researchers as well as other DEA registrants within the state of Oklahoma. Are laboratory specific DEA CS SOPs available?